20 MEDICINE PRICES SPECIAL SUPPLEMENT ESSENTIAL DRUGS MONITOR The hidden costs of essential medicines L. Levison R. Laing ➢ LIBBY LEVISON AND RICHARD LAING A N estimated one-third of the world’s…
Effective drug regulation A multicountry study by Ms Sauwakon Ratanawijitrasin Mr Eshetu Wondemagegnehu World Health Organization 2002 WHO Library Cataloguing-in-Publication Data Ratanawijitrasin,…
WHO 7 Policy on Medicines Perspectives Effective medicines regulation: ensuring safety, efficacy and quality November 2003 World Health Organization Geneva Currently about 20% of countries…
WHO Policy Perspectives on Medicines 8 Equitable access to essential medicines: a framework for collective action March 2004 World Health Organization Geneva Essential medicines save lives and…
policy the pharmaceutical scene in 2006–2007 International support for activities relating to essential medicines continues to grow. Global funding mechanisms now include not only the Global Fund to…
Criteria for Medicinal Drug Promotion Introduction 1. Following the WHO Conference of Experts on the Rational Use of Drugs held in Nairobi in November 1985, WHO prepared a revised drug strategy which…
Ethical Infrastructure for Good Governance in the Public Pharmaceutical Sector Working draft for field testing and revision November 2006 Dr Eloy Anello (WHO consultant) Department of Medicines…
WHO Policy Perspectives on Medicines Globalization, TRIPS and access to pharmaceuticals No. 3 March 2001 World Health Organization Geneva A new era in global trade TCreation of the World Trade…
Good Governance for Medicines Assessment Instrument Corruption has been identified as one of the major hurdles for development. The World Health Organization (WHO) has initiated the Good Governance…
